Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Onconova Therapeutics, Inc. (ONTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Shoemaker Mary Teresa (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.02, valued at
$67.8k
|
|
| 08/14/2023 |
4
| STOVER JACK E (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.02, valued at
$67.8k
|
|
| 08/14/2023 |
4
| Atadja Peter (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.02, valued at
$67.8k
|
|
| 08/14/2023 |
4
| Clarke Trafford (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.02, valued at
$67.8k
|
|
| 08/14/2023 |
4
| MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.02, valued at
$67.8k
|
|
| 08/14/2023 |
4
| GROOPMAN JEROME (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.02, valued at
$67.8k
|
|
| 08/14/2023 |
4
| MARINO JAMES J (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.02, valued at
$67.8k
|
|
| 08/04/2023 |
4
| Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,422 shares
@ $1.02, valued at
$1.5k
Exercised 4,750 restricted stock units
@ $0 |
|
| 08/04/2023 |
4
| Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,744 shares
@ $1.01, valued at
$4.8k
Exercised 12,567 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 79,000 options to buy
@ $0.73, valued at
$57.7k
Granted 26,000 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 207,000 options to buy
@ $0.73, valued at
$151.1k
Granted 69,333 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 62,000 options to buy
@ $0.73, valued at
$45.3k
Granted 20,667 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,977 shares
@ $1.36, valued at
$9.5k
Exercised 21,320 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,242 shares
@ $1.36, valued at
$1.7k
Exercised 5,833 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,785 shares
@ $1.36, valued at
$2.4k
Exercised 6,900 restricted stock units
@ $0 |
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| MARINO JAMES J (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.26, valued at
$83.7k
|
|
| 08/19/2022 |
4
| MEHTA VIREN (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.26, valued at
$83.7k
|
|
| 08/19/2022 |
4
| Shoemaker Mary Teresa (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.26, valued at
$83.7k
|
|
| 08/19/2022 |
4
| GROOPMAN JEROME (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 66,468 options to buy
@ $1.26, valued at
$83.7k
|
|
| 08/04/2022 |
4
| Guerin Mark Patrick (CFO AND COO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,355 shares
@ $1.32, valued at
$1.8k
Exercised 4,750 restricted stock units
@ $0 |
|
| 08/04/2022 |
4
| Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,135 shares
@ $1.32, valued at
$1.5k
Exercised 4,650 restricted stock units
@ $0 |
|
| 08/04/2022 |
4
| Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,562 shares
@ $1.32, valued at
$6k
Exercised 12,566 restricted stock units
@ $0 |
|
| 06/13/2022 |
4
| Guerin Mark Patrick (COO and CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 50,250 options to buy
@ $1.33, valued at
$66.8k
Granted 16,500 restricted stock units
@ $0 |
|
| 02/09/2022 |
4
| Gelder Mark S. MD (Chief Medical Officer) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 51,750 options to buy
@ $1.82, valued at
$94.2k
Granted 17,500 restricted stock units
@ $0 |
|
| 02/09/2022 |
4
| Fruchtman Steven M (President, Chief Executive Off) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 191,880 options to buy
@ $1.82, valued at
$349.2k
Granted 63,960 restricted stock units
@ $0 |
|
| 02/09/2022 |
4
| OLER ABRAHAM N. (SVP Corp Dev & Gen Counsel) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 54,050 options to buy
@ $1.82, valued at
$98.4k
Granted 17,633 restricted stock units
@ $0 |
|
| 02/09/2022 |
4
| Guerin Mark Patrick (CFO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 62,100 options to buy
@ $1.82, valued at
$113k
Granted 20,700 restricted stock units
@ $0 |
|
| 01/31/2022 |
4
| OLER ABRAHAM N. (SVP Corp Dev & Gen Counsel) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Bought 1,500 shares
@ $1.67, valued at
$2.5k
|
|
| 01/24/2022 |
4
| OLER ABRAHAM N. (SVP Corp Dev & Gen Counsel) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Bought 1,500 shares
@ $2.02, valued at
$3k
|
|
|
|
|